Why PAVmed Shares Are Falling Today

PAVmed Inc. PAVM shares are trading lower after the company announced a workforce reduction of roughly 20% alongside other cost-cutting measures.

What happened: PAVmed and its subsidiaries, Lucid Diagnostics Inc. LUCD and Veris Health Inc., announced Tuesday via a strategic business update that the companies have implemented a workforce reduction of 20%, which aims to reduce quarterly cash burn rate by at least 25%.

PAVmed plans to prioritize near-term commercialization for Lucid and Veris Health through:

  • Both continued research and product development for Lucid and Veris
  • Continued limited business development opportunities focused on high-value, near-term, accretive opportunities.
  • Pausing or halting all other product development activities, including CarpX, PortIO, and NextFlo
  • Pursuing additional cost-cutting measures such as not paying annual cash bonuses.

 

Lishan Aklong, M.D., PAVmed's and Lucid's Chairman and CEO, notes, "We have engaged in a systematic effort to maximize our cash runaway and protect our long-term shareholder interests while executing our strategic objectives in what remain challenging market conditions.”

PAVmed Inc is a medical device company engaged in advancing a pipeline of medical technologies from concept to commercialization using a business model focused on capital and time efficiency.

According to data from Benzinga Pro, PAVmed Inc. shares were down 18.7%, trading at $0.51 at the time of publication. It has a 52-week high of $0.62 and a 52-week low of $0.5086.

 

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: Penny StocksMoversTrading Ideaswhy it's moving
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!